Region Västmanland Report issue

Government Phase 2 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02473185
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Landstinget Västmanland | Region Västmanland

Active Ingredients

Drugs in Phase 4 Trials (1)

methylphenidate (ritalin) (2 trials)

Drugs in Phase 2 Trials (2)

autologous t cells (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

Drugs in Other Trials (2)

bilberry (1 trial)

oat (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 4)

Disease (Phase 4)

Myalgia (Phase 2)

Myofascial Pain Syndromes (Phase 2)

Substance-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5